课题基金 / 基金详情

Application of Magnetic Stealth Liposomes in External Magnetic Field for Gene Therapy -Research for the Clinical Application of New Drug Delivery System-

Application of Magnetic Stealth Liposomes in External Magnetic Field for Gene Therapy -Research for the Clinical Application of New Drug Delivery System-
磁性隐形脂质体在外磁场中应用于基因治疗-新型给药系统的临床应用研究-
批准号:
12557124
负责人:
SUGITA Takashi
金额:
$8.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SUGITA Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
我们研制了磁性ADR脂质体,在磁力作用下可以有效地输送到实体瘤中,表明静脉注射磁性ADR脂质体可以有效地将ADR输送到植入磁铁的骨肉瘤中。为了研究DDS的临床应用,我们研究了隐形脂质体(磁性ADR聚乙二醇脂质体)的效率和通过可控的磁系统而不是通过在实体瘤中植入磁铁来提高肿瘤外磁场的效率。此外,我们还研制了磁性阳离子脂质体作为基因治疗的载体,并检测了体外靶向基因表达的效率,给药后1小时,磁性ADR脂质体的血药浓度有所下降,但磁性ADR聚乙二醇脂质体的血药浓度相对保持不变。这一结果表明,血液循环中的滞留将得到改善。瘤外磁场对肿瘤的靶向效率低于瘤内磁场。我们研制了由DC-CHOL和DOPE(摩尔比为3:2)组成的磁性阳离子脂质体,并制备了DNA/脂质体复合体。我们以LacZ为报告基因。在磁场力作用下,将这些复合体导入骨肉瘤细胞。LacZ表达的Lebel值与无磁场组相比,前者在3h内较高,但在6h后两者的Lebel值基本相同,提示修饰聚乙二醇制得的隐形脂质体具有逃避肝脏Kupffer细胞摄取的作用,可减少化疗的副作用。对于这种治疗方法的临床应用,我们认为必须考察可控磁铁系统的最佳条件。由于靶细胞周围DNA/脂质体复合体浓度较高,故认为磁性阳离子脂质体可以提高基因的转染率。
英文摘要
We developed magnetic ADR liposomes which could be effectively delivered to solid tumors under magnetic force and indicated that intravenously administered magnetic ADR liposomes could be used to effectively deliver ADR to osteosarcoma implanted with a magnet. For clinical application of this DDS, we investigated the efficiency of stealth liposomes (magnetic ADR PEG-liposome) and that of magnetic field of extratumor by the controllable magnetic system not by the implantation of a magnet in a solid tumor. Furthermore we also developed magnetic cationic liposomes as a vector for gene therapy, and examined the efficiency of targeting of gene expression in vitro.The concentration of ADR in blood after administration of magnetic ADR liposomes became decreased one hour later, but that of magnetic ADR PEG-liposomes was maintained comparatively. This result demonstrated the retainment in blood circulation would be improved. The magnetic field of extratumor caused the less efficiency of targeting to tumor than that of intratumor. We developed the magnetic cationic liposomes composed of DC-chol and DOPE (3 : 2 by molar ratio) and prepared DNA/liposome complex. We used plasmid LacZ as a reporter gene. These complexes were transfected to osteosarcoma cells under magnetic force. Compared the lebel of LacZ expression with that of under no magnetic force, the former was higher within 3 hours after transfection but the both lebels of 6 hours later were almost equal.Our results suggested that the stealth liposomes by modificated of PEG resulted in the evasion from uptake by Kupffer cells of the liver and this system would reduce side effects of chemotherapy. For the clinical use of this treatment, we thought to have to examine the optimal condition of controllable magnet system. It was considered gene transfection became more efficient by magnetic cationic liposomes according to the high concentration of DNA/liposome complex around the targeted cells.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
平尾 健: "悪性骨・軟部腫瘍に対する遺伝子治療のための磁性体カチオニックリポソームの開発"日整会誌. 75・8. 1083 (2001)
Ken Hirao:“用于恶性骨和软组织肿瘤基因治疗的磁性阳离子脂质体的开发”日精学会杂志75・8(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kubo Tadahiko: "Targeted delivery of anticancer drugs with magnetic liposomes by intravenous administration in osteosarcoma-bearing hamsters."International Journal of Oncology. 17. 309-315 (2000)
Kubo Tadahiko:“通过静脉注射用磁性脂质体向患有骨肉瘤的仓鼠靶向输送抗癌药物。”国际肿瘤学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
久保忠彦: "ハムスター骨肉腫に対する静脈内投与による制癌剤封入磁性体リポソームの抗腫瘍効果."Drug Delivery System. 15・4. 343 (2000)
久保忠彦:“静脉注射抗癌药物封装的磁性脂质体对仓鼠骨肉瘤的抗肿瘤作用”15・4(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Reconstruction of vaginal microbiota to prevent and treat miscarriage and premature birth
    • 批准号:
      25460226
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      SUGITA Takashi
    • 依托单位:
    Disease control based on analysis of cutaneous microbiota in patients with psoriais
    • 批准号:
      22590150
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      SUGITA Takashi
    • 依托单位:
    Predictors of the response to therapy targeting the cutaneous microbiota in patient with atpic dermatitis
    • 批准号:
      19590164
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2007
    • 负责人:
      SUGITA Takashi
    • 依托单位:
    Treatment of atopic dermatitis based on control of microorganisms colonized skin surfface
    • 批准号:
      16590127
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2004
    • 负责人:
      SUGITA Takashi
    • 依托单位:
    国内基金
    海外基金
    靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
    诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
    • 批准号:
      81970829
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      李卓
    • 依托单位:
    Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
    • 批准号:
      81873493
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2018
    • 负责人:
      沈德良
    • 依托单位:
    以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
    • 批准号:
      81102033
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2011
    • 负责人:
      李大森
    • 依托单位: